EFPIA states AI rules must “enable not hinder” pharma R&D
Drug Discovery World
APRIL 24, 2024
Significantly for drug discovery, ‘scientific research and development’ is excluded from the scope of the Act, though this will be defined further in future guidance. They are sufficiently flexible to create the right foundation to include AI uses in the development of medicines.
52 
Let's personalize your content